Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Neurologica Belgica
Published in: Acta Neurologica Belgica 3/2019

01-09-2019 | Cranial MRI | Letter to the Editor

Posterior reversible encephalopathy syndrome caused by cerebral amyloid angiopathy-related inflammation

Authors: Pegah Masrori, Massimiliano Montagna, Eline De Smet, Caroline Loos

Published in: Acta Neurologica Belgica | Issue 3/2019

Login to get access

Excerpt

Cerebral amyloid angiopathy-related inflammation (CAA-I) is rare, but potentially treatable, distinct form of CAA. We describe a case of progressive coma and hypertension due to CAA-I, mimicking posterior reversible encephalopathy syndrome (PRES), successfully treated with immunomodulation. …
Literature
1.
Auriel E, Charidimou A, Gurol ME, Ni J, Van Etten ES, Martinez-Ramirez S et al (2016) Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol 73(2):197–202CrossRefPubMed
2.
Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA (2011) Cerebral amyloid angiopathy related inflammation: three case reports and a review. J Neurol Neurosurg Psychiatry 82(1):20–26CrossRefPubMed
3.
Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55(2):250–256CrossRefPubMed
4.
Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I et al (2013) Anti-amyloid beta autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol 73(4):449–458CrossRefPubMed
Metadata
Title
Posterior reversible encephalopathy syndrome caused by cerebral amyloid angiopathy-related inflammation
Authors
Pegah Masrori
Massimiliano Montagna
Eline De Smet
Caroline Loos
Publication date
01-09-2019
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 3/2019
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-019-01172-w

Other articles of this Issue 3/2019

Acta Neurologica Belgica 3/2019 Go to the issue

Original Article

Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension

Neuro-Images

Bilateral fronto-insular FLAIR hyperintensities: discussion on a case of new-onset refractory status epilepticus

Review article

Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach

Original article

Lacosamide in patients with intellectual disability and refractory epilepsy

Original article

The efficacy and safety of nerve combing for trigeminal neuralgia without neurovascular compression

Letter to the Editor

Widening phenotypic spectrum of GABBR2 mutation